Opioid-related legislation (2000 – 2018) 2018 Legislative Session: Summary of Opioid-Related Bills Passed Bill Number, Title and Sponsor Bill Summary H.B. 14 – Substance Abuse Treatment ▪ Remuneration for the referral of an individual for substance use disorder treatment a class A Facility Patient Brokering misdemeanor. Rep. Hutchings H.B 127 – Controlled Substance ▪ Requires a prescriber to check the Controlled Substance Database for information about a patient Database Act Amendments before the first time the prescriber gives a prescription to a patient for a Schedule II opioid or a Rep. Fawson Schedule III opioid, with the following exceptions: emergency situations and times when the Database or the Internet are down) H.B. 158 – Controlled Substance ▪ Modifies the requirements related to providing information to DOPL for inclusion in the controlled Database Revisions substance database; modifies who may be penalized for failing to submit information to the Rep. Daw controlled substance database as required by state statute. H.B. 366 – Substance Use Disorder ▪ Defines "emergency, life-saving treatment"; clarifies and requires a binding commitment to pay, Treatment Amendments rather than a "financial guarantee," when an individual seeks an order for essential treatment and Rep. Christensen intervention; allows the documentation of certain emergency, life saving treatment to qualify to reduce the number of essential treatment examinations that a court shall require; establishes procedures to follow when an individual fails to comply with a court order related to a petition for essential treatment and intervention; and allows a court to designate an individual to be a personal representative, under specified conditions. H.B. 399 – Opioid Abuse Prevention and ▪ Requires the Department of Health to develop a pamphlet with information about opiates; and Treatment Amendments requires a pharmacist who is dispensing certain prescriptions for an opiate to affix a warning label Rep. Eliason and to display an informational brochure. H.B. 434 – Controlled Substance Act ▪ Adds certain substances to the lists of controlled substances and Schedule I controlled substances. Amendments Rep. Ray H.B. 435 – Medicaid Dental Benefits ▪ Provides dental benefits to certain adults in the Medicaid program, including eligible individuals Rep. Eliason who are receiving treatment for a substance use disorder. H.J.R. 12 Joint Resolution Calling Upon ▪ Describes serious allegations that have been raised regarding deceptive marketing practices used the Attorney General to Sue Prescription by prescription opioid manufacturers to sell prescription opioids; describes the effects of the Opioid Manufacturers prescription opioid crisis on the state and nation; describes the impact of the opioid crisis on the Rep. McKell state; lists other states and Utah counties that have filed suit or committed to file suit 20 against prescription opioid manufacturers; and calls upon the attorney general to sue prescription opioid manufacturers. S.B. 205 – Incarceration Reports ▪ Requires the Department of Corrections and county jails to report to the Commission on Criminal Sen. Weiler and Juvenile Justice regarding: in-custody inmate deaths; treatment policies for inmates with a substance or alcohol addiction; and medications not dispensed to an inmate during incarceration; and requires the Commission on Criminal and Juvenile Justice to compile the information reported and submit the compilation to the Law Enforcement and Criminal Justice Interim Committee. S.C.R. 4 Concurrent Resolution on ▪ Recognizes the effects of sudden death from opioid-induced postoperative respiratory depression; Deaths from Opioid-Induced urges the Department of Health, hospitals, practitioners, and academics to further study this issue; Postoperative Respiratory Depression and encourages physicians to prescribe in-home monitoring devices where appropriate for patients Sen. Van Tassell who are discharged with opioids after surgery. 2017 Legislative Session: Summary of Opioid-Related Bills Passed Bill Number, Title and Sponsor Bill Summary H.B. 50 – Opioid Prescribing Regulations ▪ Limits prescriptions for Schedule II and Schedule III opiates for acute conditions to 7 days, with Rep. Raymond Ward exceptions (e.g., 30-day supply for post-surgical, chronic conditions). ▪ Requires a prescriber to check the Controlled Substance Database when prescribing a Schedule II or Schedule III opioid to a patient for the first time, with exceptions (e.g., < 3-day supply, post-surgical, prescriber knows the patient’s history). H.B 66 – Opiate Overdose Response Act ▪ Clarifies that overdose outreach providers and persons other than health care facilities/providers Amendments are not civilly liable when administering an opiate antagonist in good faith to a person believed to be Rep. Carol Spackman Moss experiencing an opiate-related drug overdose event. ▪ Clarifies than an overdose outreach provider may furnish an opiate antagonist to another opiate outreach provider. H.B. 90 – Insurance Opioid Regulations ▪ Authorizes a health insurer that provides prescription drug coverage to enact a policy to minimize Rep. Raymond Ward the risk of opioid addiction and overdose from: (a) chronic co-prescription of opioids with benzodiazepines and other sedating substances; (b) prescription of very high dose opioids in the primary care setting; and (c) the inadvertent transition of short-term opioids for an acute injury into long-term opioid dependence. ▪ Authorizes a health insurer that provides prescription drug coverage to enact policies to facilitate: (a) non-narcotic treatment alternatives for patients who have chronic pain; and (b) medication-assisted treatment for patients who have opioid dependence disorder. H.B. 110 – Controlled Substance ▪ Adds several spice and bath salt analogs as “listed controlled substances” in the Utah Controlled Amendments Substances Act. Rep. Paul Ray ▪ Adds U-47700 (“pink”) to Schedule I of the Utah Controlled Substances Act. ▪ Adds Acetyl fentanyl, Butyryl fentanyl, and Furanyl fentanyl to Schedule I of the Utah Controlled Substances Act. H.B. 146 – Partial Filling of a Schedule II ▪ Authorizes the partial filling of a Schedule II controlled substance for a patient other than a patient Controlled Substance Prescription in a long-term care facility or with a terminal illness, at the request of the prescriber or the patient. Rep. Stewart Barlow H.B. 175 – Opioid Abuse Prevention and ▪ Beginning with the licensing period that begins after July 1, 2024, requires controlled substances Treatment Amendments prescribers to receive 3.5 hours of training in SBIRT – Screening, Brief Intervention, and Referral to Rep. Steve Eliason Treatment – as a condition of license renewal. ▪ Permits completion of the SBIRT training to fulfill the continuing education requirement for the licensing period in which it was completed. ▪ Requires Medicaid and the Public Employees Benefit and Insurance Program to reimburse prescribers for SBIRT services provided for patients 13 years of age and older. H.B. 209 – Administration of Medication ▪ Allows for the administration of an opiate antagonist to a student in accordance with the Opiate to Students Amendment Overdose Response Act. Rep. Mike McKell H.B. 286 – Essential Treatment and ▪ Establishes a process for a relative to seek court-ordered essential treatment and intervention for Intervention Act an adult suffering from a substance use disorder, without resulting in a criminal record. Rep. LaVar Christensen S.B. 258 – Addiction Recovery ▪ Requires the Department of Health to establish guidelines for the issuance of a prescription for an Amendments Sen. Karen Mayne opiate antagonist along with a prescription for an opiate (co-prescribing). 2016 Legislative Session: Summary of Opioid-Related Bills Passed Bill Number, Title and Sponsor Bill Summary H.B. 114 – Controlled Substance This bill: amends the requirement for a general acute hospital to report to the Division of Occupational and Reporting Professional Licensing admissions for poisoning or overdose involving a prescribed controlled substance; Rep. Raymond Ward requires courts to report to the division certain violations of the Utah Controlled Substances Act; amends the purposes of the division’s controlled substance database; requires the division to enter into the database information it receives in reports by hospitals concerning persons admitted for poisoning involving a prescribed controlled substance; and requires the division to enter into the database information it receives in reports by courts concerning persons convicted for: driving under the influence of a prescribed controlled substance that renders the person incapable of safely operating a vehicle; driving while impaired, in whole or in part, by a prescribed controlled substance; or certain violations or the Utah Controlled Substances Act. Appropriation: $19,900 one-time to the Department of Commerce, Division of Occupational and Professional Licensing. H.B. 149 – Death Reporting and This bill: requires the medical examiner to provide a report to the Division of Occupational and Professional Investigation Licensing (DOPL) when the medical examiner determines that a death resulted from poisoning or overdose Information Regarding involving a prescribed controlled substance; requires that, when DOPL receives a report described in the Controlled Substances preceding paragraph, DOPL shall notify each practitioner who may have written a prescription for